跳至主要内容
临床试验/NCT06765421
NCT06765421尚未招募不适用

Optimising General Practice Long COVID Care - Feasibility Trial of a Pilot Educational Intervention.

University College Dublin0 个研究点目标入组 72 人开始时间: 2025年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
72
主要终点
Qualitative data from focus groups and post-intervention interviews

研究概览

简要总结

This trial will evaluate the feasibility of a pilot educational intervention for GPs that aims to enhance care and care outcomes among patients with long COVID at six general practices in the Ireland East region.

Our first objective is to conduct focus groups with key stakeholders (GPs, other health professionals, patients, families/carers) that will inform the contents of an education intervention. The second objective will be to implement this educational intervention, and the third objective will be to determine whether the intervention is feasible.

Study outcomes will include:

  • Qualitative findings from co-design focus groups and post-intervention semi-structured interviews with GPs.
  • Practice and patient study recruitment and retention data.
  • GP / Practice characteristics: age & gender, practice location, general and COVID-19 patient population figures.
  • Patient characteristics: Patient age, gender, COVID-19 vaccination status, and medical history details.
  • Patient scores on a self-report measure assessing the symptoms, symptom severity, functional impact, and overall health (COVID-19 Yorkshire Rehabilitation Scale (C-19-YRS)).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age: Aged 18 years or older at the time of enrolment.
  • •Registration: Are registered as patients at the study's participating practices.
  • •COVID-19 Diagnosis:
  • •Previously received a positive COVID-19 PCR or antigen test, or
  • •Previously been clinically diagnosed with COVID-19 by a healthcare provider.
  • •Persistent Symptoms:
  • •o Have spoken with their general practitioner (GP) about experiencing persistent symptoms lasting four weeks or more since their COVID-19 diagnosis.
  • •Consent: Willing and able to provide informed consent to participate in the study.

排除标准

  • •Vulnerability: Deemed by participating GPs to be a vulnerable individual whose best interests are served by not participating in the study, such as (but not limited to):
  • •People with language difficulties that prevent meaningful communication.
  • •Individuals with a recognised or diagnosed intellectual, physical, or mental impairment.
  • •Older adults considered particularly vulnerable.
  • •Individuals residing in institutions (e.g., care homes or prisons).
  • •Individuals with an unequal relationship with the researcher(s) (e.g., hierarchical dependence).
  • •Members of marginalised or disadvantaged groups for whom participation may present undue burden or risk.

研究组 & 干预措施

Intervention group

Experimental

GP practices in the intervention group will be provided with a 'long COVID Toolkit for GPs', they will be invited to attend an long COVID educational webinar, and they will be asked to perform a detailed case review of patients enrolled in the study.

干预措施: Intervention Group (Behavioral)

Control group

No Intervention

Control group GPs will be asked to deliver care as usual for patients enrolled in the study.

结局指标

主要结局

Qualitative data from focus groups and post-intervention interviews

时间窗: Focus groups (4 weeks), post intervention interviews (4 weeks).

Qualitative analyses will be used to capture focus group and intervention participants' study related views and experiences, with emphasis on accounts illustrating the intervention's feasibility.

次要结局

  • Study engagement data(12 weeks)
  • GP and patient demographics / medical details(4 weeks)
  • Patients'scores on the COVID-19-YRS(6 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验